Author:
Urayama Takeru,Cameron Roslyn,Sato Tetsuo,Yunoki Mikihiro,Ikuta Kazuyoshi
Subject
Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Reference6 articles.
1. Guidelines on the establishment of viral safety for plasma fraction products,1999
2. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Viral safety evaluation of biotechnology products derived from cell line of human or animal origin. Harmonised Tripartite Guideline Q5A(R1); 23 September 1999.
3. Viral safety of C1-inhibitor NF;Terpstra;Biologicals,2007
4. Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions;Roberts;Biologicals,2010
5. Unique morphological alterations of the HTLV-1 transformed C8166 cells by infection with HIV-1;Ongradi;Pathol Oncol Res,2000
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献